Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P120020/S037

Supera Peripheral Stent System

Abbott Vascular (Idef Technologies Inc) · Decision date Nov 6, 2026

MEDTECHLEDGER EXPLANATIONP120020/S037

What did the FDA approve?

The FDA recorded an approval decision on 2026-11-06 for P120020/S037, a Special (Immediate Track) supplement to the Supera Peripheral Stent System premarket approval held by Abbott Vascular (Idef Technologies Inc). The supplement reason is listed as a labeling change covering indications, instructions, shelf life or tradename. The recorded scope is limited to revisions of the Instructions for Use and patient guide that modify warnings, precautions and contraindications, plus the magnetic resonance imaging labeling.

This action amends labeling for an already-approved stent system; it is not a new approval of the device itself. The source record does not state which warnings, precautions, contraindications or MRI labeling text changed, nor does it include the revised documents, so the substance of the revisions remains unknown. No clinical, efficacy or patient-selection conclusions follow from this entry.

The device category is recorded as a stent for the superficial femoral artery, with product code NIP and Cardiovascular specialty. The source data do not describe components, materials or delivery system details.

FDA approval order statement

Approval for revisions to the Instructions for Use and patient guide to modify warnings, precautions and contraindications, and the magnetic resonance imaging labeling
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
Cardiovascular
Decision date
Nov 6, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P120020/S037
Regulatory pathway
PMA supplement
Product code
NIP
Decision code
APPR
Decision date
Nov 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

For the original device and its historical approval scope, see PMA P120020. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P120020 · Original PMA

    SUPERA PERIPHERAL STENT SYSTEM

  2. P120020/S037 received

    Application receipt date recorded by FDA.

  3. P120020/S037 · FDA decision

    Special (Immediate Track)

Timeline entries are records held by MedtechLedger for P120020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120020

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular (Idef Technologies Inc)PMA approvalMar 28, 2014FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular (Idef Technologies Inc)

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3200 Lakeside Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records